 |
IAspirin may provide some new benefits.
A group of researchers from Massachusetts General Hospital Institute for Technological Assessment concluded that aspirin may lower the risk of esophageal cancer. It accomplishes this by decreasing susceptibility to Barrett’s Esophagus, a condition that affects throat cells and is probably the most significant risk factor for esophageal cancer.
Barrett’s Esophagus has been rising at alarming rate during the past decade. Much of the research has been in identifying some of the early warnings of BE. Earlier studies have shown that anti-inflammatory drugs that don’t contain steroids lower death rates. There’s no research, however, involving the impact of taking aspiring and the risk of developing Barrett’s Esophagus.
According to this study, researchers in Massachusetts discovered that patients taking aspirin were 44 percent less likely to develop Barrett’s Esophagus. There were 434 patients studied. The study also indicated that men were three times as likely to develop the condition when compared to women.
The results don’t suggest that people should begin to take large doses of aspirin. Aspirin, however, has been shown to reduce the risk of many illnesses as research continues. It’s also not ideal for people to take aspirin with the main goal being to lower the risk of throat cancer, according to Dr. Chin Hur of Massachusetts General Hospital.
Still, many people may benefit if aspirin does, indeed, lower the risk of throat cancer.
